Kymera Therapeutic
+$0.53 (+2.70%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYMR and other ETFs, options, and stocks.
About KYMR
Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics.
CEO
Nello Mainolfi
Employees
141
Headquarters
Watertown, Massachusetts
Founded
2015
KYMR Key Statistics
Market cap
1.04B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.03M
High today
$20.23
Low today
$18.37
Open price
$19.86
Volume
2.09M
52 Week high
$69.12
52 Week low
$13.15
Analyst ratings
79%
of 14 ratings
Buy
78.6%
Hold
21.4%
Sell
0%
KYMR Earnings
-$0.71
-$0.47
-$0.24
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 5, Pre-Market